Jinglin Xia

4.0k total citations
107 papers, 2.8k citations indexed

About

Jinglin Xia is a scholar working on Molecular Biology, Cancer Research and Hepatology. According to data from OpenAlex, Jinglin Xia has authored 107 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Molecular Biology, 37 papers in Cancer Research and 34 papers in Hepatology. Recurrent topics in Jinglin Xia's work include Hepatocellular Carcinoma Treatment and Prognosis (27 papers), Cancer, Hypoxia, and Metabolism (16 papers) and Ferroptosis and cancer prognosis (14 papers). Jinglin Xia is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (27 papers), Cancer, Hypoxia, and Metabolism (16 papers) and Ferroptosis and cancer prognosis (14 papers). Jinglin Xia collaborates with scholars based in China, United States and Ethiopia. Jinglin Xia's co-authors include Biwei Yang, Youhua Liu, Chunsun Dai, Peixin Huang, Wenqing Tang, George K. Michalopoulos, Jia Fan, Si Zhang, Sheng‐Long Ye and Tingting Fang and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Oncogene.

In The Last Decade

Jinglin Xia

103 papers receiving 2.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jinglin Xia China 30 1.2k 702 694 674 463 107 2.8k
Asahiro Morishita Japan 29 1.3k 1.1× 876 1.2× 621 0.9× 565 0.8× 434 0.9× 177 2.9k
Henning Schulze‐Bergkamen Germany 31 1.8k 1.5× 574 0.8× 995 1.4× 607 0.9× 298 0.6× 70 3.2k
Cheng Huang China 32 1.3k 1.1× 915 1.3× 405 0.6× 716 1.1× 281 0.6× 114 2.9k
Hong‐Yang Wang China 20 1.3k 1.1× 734 1.0× 832 1.2× 922 1.4× 154 0.3× 30 3.0k
Ja June Jang South Korea 33 1.7k 1.5× 741 1.1× 887 1.3× 749 1.1× 575 1.2× 94 3.6k
Amelie Plymoth Sweden 17 1.6k 1.3× 1.1k 1.6× 781 1.1× 1.3k 1.9× 681 1.5× 28 3.9k
Taoyang Chen China 36 2.1k 1.8× 1.5k 2.2× 621 0.9× 538 0.8× 325 0.7× 93 3.5k
Hayato Hikita Japan 29 1.7k 1.4× 723 1.0× 600 0.9× 842 1.2× 240 0.5× 133 3.6k
Kazuhiro Katayama Japan 30 1.3k 1.1× 310 0.4× 1.4k 2.0× 459 0.7× 300 0.6× 136 3.3k
Kunihiko Izuishi Japan 30 653 0.5× 368 0.5× 575 0.8× 455 0.7× 528 1.1× 98 2.6k

Countries citing papers authored by Jinglin Xia

Since Specialization
Citations

This map shows the geographic impact of Jinglin Xia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jinglin Xia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jinglin Xia more than expected).

Fields of papers citing papers by Jinglin Xia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jinglin Xia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jinglin Xia. The network helps show where Jinglin Xia may publish in the future.

Co-authorship network of co-authors of Jinglin Xia

This figure shows the co-authorship network connecting the top 25 collaborators of Jinglin Xia. A scholar is included among the top collaborators of Jinglin Xia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jinglin Xia. Jinglin Xia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Lingxiao, Shiguang Yang, Jie Li, et al.. (2025). YAP-activated NAT10 promotes hepatoblastoma progression by activating the pentose phosphate pathway. International Journal of Biological Sciences. 21(6). 2864–2879. 1 indexed citations
2.
Wang, Heming, Yun Chen, Dong-Ping Li, et al.. (2025). Phosphocreatine alleviates monocrotaline-induced liver injury dependent on PSRC1-regulated endoplasmic reticulum stress. Biochemical Pharmacology. 237. 116915–116915.
3.
Sun, Jialei, et al.. (2025). PIP5K1A Suppresses Ferroptosis and Induces Sorafenib Resistance by Stabilizing NRF2 in Hepatocellular Carcinoma. Advanced Science. 12(30). e04372–e04372.
4.
Pan, Yating, Jinrong Zhu, Dongrui R. Lu, et al.. (2024). PH-sensitive adriamycin hydrochloride and oxaliplatin dual-loaded microspheres synergistically enhance local injections effect of hepatocellular carcinoma. Materials Today Bio. 29. 101311–101311. 2 indexed citations
5.
Pan, Yating, et al.. (2024). Disulfiram/Cu targeting FOXO6 modulates sensitivity of hepatocellular carcinoma to lenvatinib via disrupt choline metabolic. Cellular Signalling. 127. 111563–111563. 1 indexed citations
6.
7.
8.
9.
Du, Xiaojing, et al.. (2023). HELLS modulates the stemness of intrahepatic cholangiocarcinoma through promoting senescence-associated secretory phenotype. Computational and Structural Biotechnology Journal. 21. 5174–5185. 5 indexed citations
10.
Qiao, Xiaoyan, et al.. (2023). Urate oxidase from tea microbe Colletotrichum camelliae is involved in the caffeine metabolism pathway and plays a role in fungal virulence. Frontiers in Nutrition. 9. 1038806–1038806. 8 indexed citations
11.
Xie, Shicheng, et al.. (2023). Novel risk model based on angiogenesis-related lncRNAs for prognosis prediction of hepatocellular carcinoma. Cancer Cell International. 23(1). 159–159. 4 indexed citations
12.
Shi, Qing, Xingxing Zhang, Yuhan Xia, et al.. (2023). Emulsifying Lipiodol with pH-sensitive DOX@HmA nanoparticles for hepatocellular carcinoma TACE treatment eliminate metastasis. Materials Today Bio. 23. 100873–100873. 9 indexed citations
13.
14.
Du, Xiaojing, et al.. (2022). Loss of GABARAPL1 confers ferroptosis resistance to cancer stem‐like cells in hepatocellular carcinoma. Molecular Oncology. 16(20). 3703–3719. 22 indexed citations
15.
Du, Xiaojing, Biwei Yang, Quanlin An, et al.. (2021). Acquired resistance to third-generation EGFR-TKIs and emerging next-generation EGFR inhibitors. The Innovation. 2(2). 100103–100103. 101 indexed citations
16.
Feng, Qi, Wenxing Qin, Yao Zhang, et al.. (2021). Sulfarotene, a synthetic retinoid, overcomes stemness and sorafenib resistance of hepatocellular carcinoma via suppressing SOS2-RAS pathway. Journal of Experimental & Clinical Cancer Research. 40(1). 17 indexed citations
17.
Wu, Jian, Ruolei Xin, Ya Ni, et al.. (2016). Phylogeographical Analysis Reveals Distinct Sources of HIV-1 and HCV Transmitted to Former Blood Donors in China. AIDS Research and Human Retroviruses. 33(3). 284–289. 3 indexed citations
18.
Fang, Tingting, Jiayun Hou, Mingyan He, et al.. (2016). Actinidia chinensis Planch root extract (acRoots) inhibits hepatocellular carcinoma progression by inhibiting EP3 expression. Cell Biology and Toxicology. 32(6). 499–511. 31 indexed citations
19.
Wang, Yaohui, Weimin Wang, Lingyan Wang, Xiangdong Wang, & Jinglin Xia. (2011). Regulatory mechanisms of interleukin‐8 production induced by tumour necrosis factor‐α in human hepatocellular carcinoma cells. Journal of Cellular and Molecular Medicine. 16(3). 496–506. 40 indexed citations
20.
Espat, N. Joseph, J J Lewis, James M. Woodruff, et al.. (2000). Confirmed Angiosarcoma: Prognostic Factors and Outcome in 50Prospectively Followed Patients. Sarcoma. 4(4). 173–177. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Asahiro Morishita Breakdown of academic impact, for papers by Henning Schulze‐Bergkamen Breakdown of academic impact, for papers by Cheng Huang Breakdown of academic impact, for papers by Hong‐Yang Wang Breakdown of academic impact, for papers by Ja June Jang Breakdown of academic impact, for papers by Amelie Plymoth Breakdown of academic impact, for papers by Taoyang Chen Breakdown of academic impact, for papers by Hayato Hikita Breakdown of academic impact, for papers by Kazuhiro Katayama Breakdown of academic impact, for papers by Kunihiko Izuishi
Rankless by CCL
2026